Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS Roll out of Body Cameras in Boost to Ambulance Crews Safety
Thousands of ambulance crews across the country will be provided with body cameras as part […]
New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation
Increasing consent rates for organ donation and making the most of donated organs for transplant […]
NHS Treats First Patient with the ‘World’s Most Expensive Drug’
A five-month old baby has become the first patient to receive a potentially life-saving drug […]
Portable ECG Device to be Further Rolled Out After Successful Pilot
A portable ECG monitoring device that detects heart irregularities is to be rolled out across […]
Study into Whether Vaccination of Previously Infected Generates Stronger, Broader Coronavirus Antibody Response
NHS Blood and Transplant (NHSBT) is carrying out a study in the Birmingham region aimed […]
Vaccine Status Drives Over One Million New Users to the NHS App
Over 1.3 million new people have registered to use the NHS App since the addition […]
60 Million Doses of Covid-19 Vaccine Administered in UK
Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]
Doctorlink Approved for NHS Procurement Framework
Doctorlink has today announced that its Online Consultation and Video Consultation solutions have been approved for NHS England’s Digital […]
Digital Healthcare Company Healios Gets £7M to Offer Tailored Therapy to Children and Young People Across the UK
Based out of Southampton, Healios is a digital healthcare company working to empower patients and families affected […]
Ambulance iPads Improve Patient Care Under NHS Long Term Plan
Tens of thousands of iPads will be issued to ambulance crews across England so that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more